Covered recipient · General Payments record
DANA MOURAD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$308.22
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $287.07 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $74.07 | 4 |
| Daiichi Sankyo Inc. | $59.26 | 3 |
| Phathom Pharmaceuticals, Inc. | $24.37 | 1 |
| SANOFI-AVENTIS U.S. LLC | $23.62 | 1 |
| Merck Sharp & Dohme Corporation | $21.09 | 1 |
| Amgen Inc. | $19.45 | 1 |
| Lilly USA, LLC | $18.52 | 1 |
| Acerta Pharma LLC | $15.99 | 1 |
| Phadia US Inc. | $15.62 | 1 |
| Novo Nordisk AS | $15.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.29 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074449 | CMS |
| ABBVIE INC. | $17.77 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074451 | CMS |
| ABBVIE INC. | $19.51 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074453 | CMS |
| ABBVIE INC. | $19.50 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074455 | CMS |
| Amgen Inc. | $19.45 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333936 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.99 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104407797 | CMS |
| Daiichi Sankyo Inc. | $18.58 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089460000 | CMS |
| Daiichi Sankyo Inc. | $20.18 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089460002 | CMS |
| Daiichi Sankyo Inc. | $20.50 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089459998 | CMS |
| Lilly USA, LLC | $18.52 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136124775 | CMS |
| Merck Sharp & Dohme LLC | $21.09 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141733863 | CMS |
| Novo Nordisk Inc | $15.08 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097586602 | CMS |
| Phadia US Inc. | $15.62 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067577534 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.37 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151099177 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.62 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139838729 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.